SCARB1 and neoplasm: Yuan and colleagues leveraged the high expression of scavenger receptor SR-B1 on mDCs and used nanoparticles (α-Ap-FNP) with SR-B1-targeting capabilities to directly transport tumor antigen peptides to DCs in lymph nodes, which resulted in significant inhibition of tumor growth 102.